Latest Reports

ASIA PACIFIC EPIGENOMICS MARKET 2018-2026

The Asia-Pacific epigenomics market is expected to register the highest CAGR of 20.57% over the forecast period of 2018-2026.  Positive economic outlook and the rising consumer awareness of the benefits of therapeutic drugs is expected to augment this market’s growth over the forecast years. ASIA PACIFIC EPIGENOMICS MARKET 2018-2026 Request free sample Report SummaryTable of ContentsSegmentationRequest Free SampleReport Summary The Asia-Pacific epigenomics market is expected to register the highest CAGR of 20.57% over the forecast... Read more

GLOBAL METASTATIC CANCER TREATMENT MARKET FORECAST 2018-2026

The Global Metastatic cancer treatment market is anticipated to grow at a CAGR of 7.13% between 2018 and 2026. A metastasis or metastatic cancer is the spread of cancer cells from the place where they first formed to another part of the body. The Metastatic cancer treatment market is primarily driven by the following factors: GLOBAL METASTATIC CANCER TREATMENT MARKET FORECAST 2018-2026 Global Metastatic Cancer Treatment Market by Therapeutic Indication (Breast Cancer, Prostate Cancer, Lung... Read more

GLOBAL EPIGENOMICS MARKET FORECAST 2018-2026

 The global epigenomic market is estimated to grow with approx.18.25% CAGR during the year 2018-2026. Epigenomics can be defined as the study of the whole set of epigenetic modifications on the genetic material of a cell, known as the epigenome. The global epigenomic market is primarily driven by the following factors: Increase in the prevalence of cancer and other chronic diseases GLOBAL EPIGENOMICS MARKET FORECAST 2018-2026 Global Epigenomics Market by Product (Reagents, Kits, Instruments, Enzymes, Services) by... Read more

GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET FORECAST 2018-2026

The Global Cell-free DNA (cfDNA) testing market is anticipated to grow at a CAGR of 18.52% in terms of a number of units and 16.46% in terms of revenue between 2018 and 2026. Cell-free DNA testing has been a new technology in which free-flowing DNA fragments, from a small quantity of liquid sample (saliva, urine, or blood) from patients, are analyzed. The Cell-free DNA (cfDNA) testing market is primarily driven by the following factors: GLOBAL... Read more

NORTH AMERICA 3D MEDICAL IMAGING MARKET FORECAST 2020-2028

The North American market of 3D medical imaging is predicted to register a CAGR of 5.71% during the forecasted period, 2020-2028. The market growth in the North American region is driven mainly by the growing number of surgeries due to the widespread presence of chronic diseases like cancer. The 3D medical imaging market of North America is segmented into the US and Canada for further evaluation. The US dominates the market growth in the region of... Read more